| Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial HA Tawbi, M Burgess, V Bolejack, BA Van Tine, SM Schuetze, J Hu, ... The Lancet Oncology 18 (11), 1493-1501, 2017 | 1111 | 2017 |
| Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1133-1144, 2008 | 576 | 2008 |
| Correlative analyses of the SARC028 trial reveal an association between sarcoma-associated immune infiltrate and response to pembrolizumab EZ Keung, M Burgess, R Salazar, ER Parra, J Rodrigues-Canales, ... Clinical Cancer Research 26 (6), 1258-1266, 2020 | 135 | 2020 |
| Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial N Somaiah, AP Conley, ER Parra, H Lin, B Amini, LS Soto, R Salazar, ... The Lancet Oncology 23 (9), 1156-1166, 2022 | 56 | 2022 |
| CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma P Rocha, R Salazar, J Zhang, D Ledesma, JL Solorzano, B Mino, ... Cancer Immunology, Immunotherapy 70, 1965-1976, 2021 | 24 | 2021 |
| The immune landscape of undifferentiated pleomorphic sarcoma R Lazcano, CM Barreto, R Salazar, F Carapeto, RS Traweek, CH Leung, ... Frontiers in Oncology 12, 1008484, 2022 | 11 | 2022 |
| Pembrolizumab in advanced soft tissue and bone sarcomas: results of SARC028, a multicentre, single arm, phase 2 trial HA Tawbi, M Burgess, V Bolejack, BA Van Tine, SM Schuetze, J Hu, ... The Lancet. Oncology 18 (11), 1493, 2017 | 7 | 2017 |
| P1. 04-22 CD73 Immunohistochemical Expression in Malignant Cells and Correlation with Immune Infiltrate in Non-Small Cell Lung Carcinoma (NSCLC) R Salazar, J Solorzano, L Solis, C Behrens, B Mino, E Parra, J Zhang, ... Journal of Thoracic Oncology 13 (10), S533-S534, 2018 | 1 | 2018 |
| Rare and Usual Case of Intramedulary Spinal Cord Neurofibroma J Jedrzkiewicz, R Salazar, JS Winberg JSM Spine (1) 1003, 2016 | 1 | 2016 |
| Linfoma plasmablástico: un caso con enfermedad rectal y compromiso de médula ósea en un paciente VIH positivo G García Chihuan, A Fernández Butrón, R Salazar Alejo, O Frisancho, ... Revista de Gastroenterología del Perú 34 (4), 347-350, 2014 | 1 | 2014 |
| CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma (Jan, 10.1007/s00262-020-02820-4, 2021) P Rocha, R Salazar, J Zhang, D Ledesma, JL Solorzano, B Mino, ... CANCER IMMUNOLOGY IMMUNOTHERAPY 70 (7), 1977-1978, 2021 | | 2021 |
| Immune Landscape Differences in Alveolar Soft Part Sarcoma and Undifferentiated Pleomorphic Sarcoma S Gite, LS Soto, CN Barreto, R Salazar, D Ingram, K Wani, I Wistuba, ... LABORATORY INVESTIGATION 101 (SUPPL 1), 46-47, 2021 | | 2021 |
| Characterization of immune cell biomarkers in undifferentiated pleomorphic sarcoma CM Barreto, LM Solis-Soto, R Salazar, S Gite, ER Parra, B Mino, D Ingram, ... Cancer Research 80 (16_Supplement), 3857-3857, 2020 | | 2020 |
| The influence of Durvalumab/Tremelimumab Combination Therapy on Sarcomas Immune Microenvironment profile in a phase II clinical trial (NCT02815995) E Parra, C Barreto, R Salazar, C Haymaker, H Lin, C Behrens, M Jiang, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | | 2019 |
| P1. 04-79 CD73 Expression in Lung Adenocarcinomas and Immunological and Molecular Associations P Rocha, R Salazar, J Solorzano, J Zhang, B Mino, E Parra, D Ledesma, ... Journal of Thoracic Oncology 14 (10), S473, 2019 | | 2019 |
